DTIL as of Oct 31 · 14:58 ET
DTILNasdaqBiological Products, (No Diagnostic Substances)

Precision Biosciences Inc · Brief

Next report

2 days

Nov 2 · before openest.Q3 FY26

Expected move

Inputs

Implied vs realized

8 reportsHistory
—≥ implied
Mar 26 '25—▼−11.00%—
May 15 '25—▼−8.08%—
Aug 7 '25—▼−4.99%—
Q3 FY25—▼−9.80%—
Jan 13 '26—▲+0.49%—
Q1 FY26—▲+12.06%—
May 5 '26—▼−2.36%—
Q2 FY26±36.7%▼−0.67%×0.02
quarterimplied−40%0+40%realized×
Q2 FY26±36.7%▼−0.67%×0.02
May '26—▼−2.36%—
Q1 FY26—▲+12.06%—
Jan '26—▲+0.49%—
Q3 FY25—▼−9.80%—
Aug '25—▼−4.99%—
2 older reports
May '25—▼−8.08%—
Mar '25—▼−11.00%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · est.

Bull2

96managers reporting a position in the latest quarterly filings13F · Jun 30 '26
14managers holding most of reported value13F · Jun 30 '26

Bear2

5 of 23largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
−2.33%change in shares held by the largest reporting managers over the latest quarter13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

DTIL report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±84.2% into Nov 2 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.